Profile
Full Name
Keros Therapeutics, Inc.Ticker Symbol
KROSExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
April 8, 2020Indexes
Not includedWebsite
http://www.kerostx.comEmployees
169Key Details
Price
$12.18(-0.49%)
Market cap
$494.05M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$3.55M(+2250.99% YoY)
Annual EPS
-$5.00(+3.85% YoY)
PE ratio
-
Next earnings date
May 8, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Keros Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 9, 25 Truist Securities
BuyApr 1, 25 Wedbush
NeutralApr 1, 25 HC Wainwright & Co.
BuyFeb 27, 25 Wells Fargo
OverweightFeb 27, 25 HC Wainwright & Co.
BuyJan 21, 25 Cantor Fitzgerald
NeutralJan 17, 25 Wedbush
NeutralJan 17, 25 Piper Sandler
OverweightJan 17, 25 Guggenheim
NeutralJan 16, 25 Scotiabank
Sector OutperformInstitutional Ownership
- What is the ticker symbol for Keros Therapeutics?
- Does Keros Therapeutics pay dividends?
- What sector is Keros Therapeutics in?
- What industry is Keros Therapeutics in?
- What country is Keros Therapeutics based in?
- When did Keros Therapeutics go public?
- Is Keros Therapeutics in the S&P 500?
- Is Keros Therapeutics in the NASDAQ 100?
- Is Keros Therapeutics in the Dow Jones?
- When was Keros Therapeutics's last earnings report?
- When does Keros Therapeutics report earnings?
- Should I buy Keros Therapeutics stock now?
What is the ticker symbol for Keros Therapeutics?
The ticker symbol for Keros Therapeutics is NASDAQ:KROS
Does Keros Therapeutics pay dividends?
No, Keros Therapeutics does not pay dividends
What sector is Keros Therapeutics in?
Keros Therapeutics is in the Healthcare sector
What industry is Keros Therapeutics in?
Keros Therapeutics is in the Biotechnology industry
What country is Keros Therapeutics based in?
Keros Therapeutics is headquartered in United States
When did Keros Therapeutics go public?
Keros Therapeutics's initial public offering (IPO) was on April 8, 2020
Is Keros Therapeutics in the S&P 500?
No, Keros Therapeutics is not included in the S&P 500 index
Is Keros Therapeutics in the NASDAQ 100?
No, Keros Therapeutics is not included in the NASDAQ 100 index
Is Keros Therapeutics in the Dow Jones?
No, Keros Therapeutics is not included in the Dow Jones index
When was Keros Therapeutics's last earnings report?
Keros Therapeutics's most recent earnings report was on Feb 26, 2025
When does Keros Therapeutics report earnings?
The next expected earnings date for Keros Therapeutics is May 8, 2025
Should I buy Keros Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions